1. |
Details of PDMR/person closely associated with them ('PCA') |
a) |
Name |
Mr S Dingemans |
b) |
Position/status |
Chief Financial Officer |
c) |
Initial notification/ amendment |
Initial notification |
2. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
a) |
Name |
GlaxoSmithKline plc |
b) |
LEI |
5493000HZTVUYLO1D793 |
3. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted |
a) |
Description of the financial instrument |
Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882 |
b) |
Nature of the transaction |
Acquisition of Ordinary Shares on 1 December 2017 following the exercise of options granted on 29 October 2014 at the option price of £11.31 per Ordinary Share under the Company's ShareSave Plan. |
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
£11.31 |
238 |
|
d) |
Aggregated information Aggregated volume Price |
n/a (single transaction) |
e) |
Date of the transaction |
2017-12-01 |
f) |
Place of the transaction |
London Stock Exchange (XLON) |